GBP511
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GBP511, covering 2026-02-12 to 2026-02-12. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults. [Phase 1, Phase 2]